ABCG2 and non-small cell lung carcinoma: In Zhang et al.’s study, a mitoxantrone-selected MDR cell model that is cross-resistant to TPT due to ABCG2 overexpression was used; however, the effect of CBZ in reversing TPT resistance has not been verified from a TPT-selected resistant NSCLC model.